Z. Zhu et al., PENETRATION KINETICS OF 5-FLUOROURACIL INTO PANCREATIC FLUID IN POST-PANCREATICODUODENECTOMY PATIENTS, Anti-cancer drugs, 9(8), 1998, pp. 685-688
Our aim was to investigate the pharmacokinetic behavior of 5-fluoroura
cil (5-FU) in pancreatic fluid and to evaluate its penetration charact
eristics in post-pancreatoduodenectomy patients, After completing the
external drainage of the pancreatic duct during pancreatoduodenectomy
surgery, eight patients were administered 1.0 g 5-FU i.v. by a 5 min i
nfusion after the eighth day post-surgery on average. Blood and pancre
atic fluid were collected, and the 5-FU concentrations were determined
by HPLC assay, Their pharmacokinetic parameters were obtained by PCNO
NLIN and statistical analysis was performed. The C-max was 20.03 +/- 1
8.25 mg/l in pancreatic fluid with a T-max of 15.6 +/- 9.5 min followi
ng i.v. administration and 49.69 +/- 20.75 mg/l in plasma. 5-FU in pla
sma and pancreatic fluid were all in conformity with a non-linear mode
l with a K-m of 1098.08 +/- 1426.57 and 11.08 +/- 6.38 mg/l, respectiv
ely, The concentrations in pancreatic fluid were similar to that obser
ved in plasma with an average penetration index up to 1.01 +/- 0.49. I
t is suggested therefore that 5-FU is capable of penetrating from bloo
d into the pancreas as evidenced by the observed pancreatic concentrat
ions, [(C) 1998 Lippincott Williams & Wilkins.].